Ethics of Resource Allocation across the Lifespan
Ethics of Resource Allocation across the LifespanMildred Solomon, president and chief executive officer for the Hastings Center and Director of the Fellowship of Bioethics at Harvard Medical School,...
View ArticleA Conversation with Dr. Marcia Angell
A Conversation with Dr. Marcia Angell In this candid interview with Christine Mitchell, Executive Director of the Center for Bioethics, Dr. Angell discusses the progress that has been made in medical...
View ArticleWhat Would You Do? Juggling Bioethics and Ethnography
What Would You Do? Juggling Bioethics and Ethnography A Conversation with Charles Bosk, December 10th at Harvard Medical School
View ArticleStudent Essays On “Philosophers On Drug Prices”
Student Essays On “Philosophers On Drug Prices”December 1, 2015Daily NousStudents On “Philosophers On Drug Prices”Research ethics essays by the 2015-2016 cohort of Master of Bioethics students, as...
View ArticleBlood Lines: Fatherhood, faith and love in the time of stem cells
Blood Lines: Fatherhood, faith and love in the time of stem cellsJanuary 22, 201612:30-2:00 pm1st Floor Conference RmCenter for Bioethics, Harvard Medical School641 Huntington AvenueBoston, MA 02115
View ArticleResource Document May Provide Guide to Ethical Issues in Everyday Practice
Resource Document May Provide Guide to Ethical Issues in Everyday PracticePsychiatric News, Psychiatry OnlineMark Moran November 13, 2015Rebecca Brendel, MD, JD, describes the resource document as a...
View ArticleA Community of Critical Friends
A Community of Critical FriendsProgram in Bioethics strives for fellowship in all senses
View ArticleThe Question of Clinical Equipoise and Patients’ Best Interests
The Question of Clinical Equipoise and Patients’ Best InterestsCommentary by Spencer Phillips Hey, PhD, and Robert D. Truog, MDAMA Journal of Ethics. December 2015, Volume 17, Number 12: 1108-1115.
View Article2016 Bioethics Conference
2016 Bioethics ConferenceMark your calendar now for the Annual Bioethics Conference at Harvard Medical School in Boston, MA, April 14, 2016.
View ArticleWhen You Suspect a Colleague is Impaired
When You Suspect a Colleague is ImpairedWhen to approach a colleague or a superior, how to, and what the consequences can be. In this webcast, Center faculty member J. Wesley Boyd, MD, PhD helps us...
View ArticleSpencer Hey: Unpacking the Clinical Research Portfolio
Spencer Hey: Unpacking the Clinical Research PortfolioIn Dr. Spencer Hey's Research Ethics class, Master of Bioethics students discuss and debate the life cycle of clinical translation.
View ArticleLachlan Forrow, M.D. honored by the Massachusetts Medical Society
Lachlan Forrow, M.D. honored by the Massachusetts Medical SocietyPhysician is honored with state medical society's award for leadership in public health
View ArticleAn Uninformative Truth: The Logic of Amarin's Off-Label Promotion
An Uninformative Truth: The Logic of Amarin's Off-Label PromotionCenter faculty members Dr. Spencer Hey and Dr. Aaron Kesselheim examined a lawsuit filed by Amarin Pharmaceutical in May 2015 that...
View ArticleThos Cochrane: Connecting Morality and the Mind
Thos Cochrane: Connecting Morality and the MindHow one faculty member defines the world of neuroethics
View ArticleEthical Imperative and Moral Challenges of Engaging Patients and the Public...
Ethical Imperative and Moral Challenges of Engaging Patients and the Public with Health Care EvidenceA national conversation about the evidence behind health care and health policy options is an...
View ArticleOf medicine and ethics
Of medicine and ethicsHarvard GazetteBy John Laidler, Harvard CorrespondentShifts in the field can allow providers both to prosper and serve patients better, speaker James Corbett says.
View ArticleBuilding a Biomedical Information Commons: Ethical and Policy Issues
Building a Biomedical Information Commons: Ethical and Policy Issues Explore the pros and cons of managing genetic information via public and proprietary companies.
View ArticleFDA panel rejects Sarepta drug to treat Duchenne muscular dystrophy
FDA panel rejects Sarepta drug to treat Duchenne muscular dystrophyThe Boston GlobeBy Robert WeismanCommittee member Aaron S. Kesselheim, associate professor at Harvard Medical School, said “the...
View ArticleInnovation in Neurosurgery
Innovation in NeurosurgeryIf a neurosurgeon develops a new technique, when can it be considered innovation, and when should it be considered investigation?
View ArticleWhen the Seriously Ill Want to Donate Organs
When the Seriously Ill Want to Donate OrgansThe Wall Street JournalJune 24, 2016By Amy Dockser MarcusDavid Adox had ALS and wanted to be an organ donor. But it wasn’t easy to make it happen.
View Article
More Pages to Explore .....